AK
Anurag Kastwar
About Anurag Kastwar
Data last updated:
Anurag Kastwar is a Managing Director at Gracrux Pharmaceuticals Private Limited (since 2015). The companies operate in Professional Services and Pharma. Gracrux Pharmaceuticals Private Limited reported revenue of ₹8.7 Lakh (FY 2025). Earlier, Anurag Kastwar was an Additional Director at Sharda Medicoss Private Limited (2016–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 18 May 2015 | 2015 | ₹8.7 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 15 Sep 2016 | 2014 | ₹34.4 Lakh (FY 2019) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anurag Kastwar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anju Anurag Kastwar | 07171065 | Gracrux Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anurag Kastwar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anurag Kastwar
Anurag Kastwar currently holds 1 directorship: Gracrux Pharmaceuticals Private Limited (Managing Director, since 18 May 2015, revenue ₹8.7 Lakh (FY 2025)).
Anurag Kastwar was first appointed on 18 May 2015 as Managing Director at Gracrux Pharmaceuticals Private Limited. The most recent appointment on record is 15 Sep 2016 at Sharda Medicoss Private Limited.
Anurag Kastwar held 1 earlier board appointment: Sharda Medicoss Private Limited (Additional Director, 15 Sep 2016 to 02 Mar 2017).
The current boards of Anurag Kastwar's companies include Anju Anurag Kastwar (Gracrux Pharmaceuticals Private Limited).